Evidence mapPaperPMID 39093465Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2025

A novel pharmacological strategy using nanoparticles with glutathione and virgin coconut oil to treat gentamicin-induced acute renal failure in rats.

Mahmoud S Sabra, Essmat A H Allam, Mohamed Abd El-Aal, Nessma H Hassan, Al-Hassan Mohammed Mostafa, Ahmed A N Ahmed

Abstract read
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mahmoud S SabraPharmacology Department, Faculty of Veterinary Medicine, Assiut University, Assiut, 71526, Egypt. Mahmoud_Sabra@aun.edu.eg.
Essmat A H AllamDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Assiut University, Assiut, 71526, Egypt.
Mohamed Abd El-AalChemistry Department, Faculty of Science, Assiut University, Assiut, 71516, Egypt.
Nessma H HassanDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Assiut University, Assiut, 71526, Egypt.
Al-Hassan Mohammed MostafaDepartment of Pathology and Clinical Pathology, Agricultural Research Centre, Animal Health Research Institute, Assiut, 71526, Egypt.
Ahmed A N AhmedPharmacology Department, Faculty of Medicine, Al-Azhar University, Assiut Branch, , Assiut, 71526, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In acute renal failure (ARF), the glomerular filtration rate is reduced, and nitrogenous waste products accumulate persistently, which can last anywhere from a few hours to several days. There is hope for a reversal of the rapid loss of renal function caused by this condition. This study, with gentamicin-induced acute ARF as a prospective setting, sets out to examine the reno-protective benefits of virgin coconut oil (VCO) and GSH. Furthermore, the study evaluated the effect of medication nanoparticle compositions on several kidney function markers. The induction of ARF is achieved with the intraperitoneal injection of gentamicin. To assess renal function, rats underwent 24 h of dehydration and hunger before their deaths. The study examined various aspects, including kidney function tests, markers of oxidative stress, histology of kidney tissue, inflammatory cytokines, immunohistochemistry expression of nuclear factor-kappa B (NF-κB), and specific biomarkers for kidney tissue damage, such as kidney injury molecule-1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL). The results of our study indicated that the combination of VCO and GSH, using both regular and nanoparticle formulations, had a better protective impact on the kidneys compared to using either drug alone. The recovery of renal tissue and serum markers, which are symptomatic of organ damage, indicates improvement. This was also demonstrated by the reduction in tubular expression of TNF-α, IL-1β, KIM-1, and NGAL. The immunohistochemical studies showed that the combination therapy, especially with the nanoforms, greatly improved the damaged cellular changes in the kidneys, as shown by higher levels of NF-κB. The study shows that VCO and GSH, when administered individually or combined, significantly improve ARF in a gentamicin-induced rat model, highlighting potential therapeutic implications. Notably, the combined nanoparticulate formulations exhibit substantial effectiveness.

Indexed as

Acute Kidney InjuryCoconut OilGentamicinsGlutathioneNanoparticlesAnimalsBiomarkersCell Adhesion MoleculesCytokinesDisease Models, AnimalKidneyLipocalin-2MaleNF-kappa BOxidative StressRatsBiomarkersCell Adhesion MoleculesCoconut OilCytokinesGentamicinsGlutathioneHavcr1 protein, ratLipocalin-2NF-kappa BARFGentamicinGSHKIM-1NanoparticlesNGAL

Identifiers

PMID39093465
PMCPMC11787276

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.